PDR Update

  • Key
  • Boxed Warning
  • Other Warnings*

    *Warnings and Precautions; Adverse Reactions; Drug Interactions; and Contraindications

  • Updates to Indications/Dosage
  • Other Updates†

    †Other labeling changes; added to PDR database

No Avycaz boxed warning Avycaz has Other Warnings No Avycaz Indications/Dosage Updates Avycaz has Other Updates Avycaz (avibactam/ceftazidime)
No Brukinsa boxed warning No Brukinsa Other Warnings No Brukinsa Indications/Dosage Updates Brukinsa has Other Updates Brukinsa (zanubrutinib)
No Depakote ER boxed warning No Depakote ER Other Warnings Depakote ER has Indications/Dosage Updates Depakote ER has Other Updates Depakote ER (divalproex sodium)
No Depakote Sprinkle Capsules boxed warning Depakote Sprinkle Capsules has Other Warnings Depakote Sprinkle Capsules has Indications/Dosage Updates Depakote Sprinkle Capsules has Other Updates Depakote Sprinkle Capsules (divalproex sodium)
No Depakote Tablets boxed warning Depakote Tablets has Other Warnings Depakote Tablets has Indications/Dosage Updates Depakote Tablets has Other Updates Depakote Tablets (divalproex sodium)
No Liletta SHI boxed warning Liletta SHI has Other Warnings No Liletta SHI Indications/Dosage Updates Liletta SHI has Other Updates Liletta SHI (levonorgestrel)
No Lo Loestrin Fe boxed warning No Lo Loestrin Fe Other Warnings No Lo Loestrin Fe Indications/Dosage Updates Lo Loestrin Fe has Other Updates Lo Loestrin Fe (ethinyl estradiol/ferrous fumarate/norethindrone acetate)
No Lupron Depot-PED boxed warning Lupron Depot-PED has Other Warnings Lupron Depot-PED has Indications/Dosage Updates Lupron Depot-PED has Other Updates Lupron Depot-PED(leuprolide acetate)
No Oriahnn boxed warning No Oriahnn Other Warnings No Oriahnn Indications/Dosage Updates Oriahnn has Other Updates Oriahnn(elagolix/estradiol/norethisterone)
No Orilissa boxed warning Orilissa has Other Warnings No Orilissa Indications/Dosage Updates Orilissa has Other Updates Orilissa(elagolix)
No Ozurdex boxed warning No Ozurdex Other Warnings No Ozurdex Indications/Dosage Updates Ozurdex has Other Updates Ozurdex (dexamethasone)
No Qulipta boxed warning Qulipta has Other Warnings Qulipta has Indications/Dosage Updates Qulipta has Other Updates Qulipta(atogepant)
No Rinvoq boxed warning Rinvoq has Other Warnings Rinvoq has Indications/Dosage Updates Rinvoq has Other Updates Rinvoq(upadacitinib)
No Skyrizi boxed warning Skyrizi has Other Warnings Skyrizi has Indications/Dosage Updates Skyrizi has Other Updates Skyrizi (risankizumab-rzaa)
No Synthroid boxed warning Synthroid has Other Warnings Synthroid has Indications/Dosage Updates Synthroid has Other Updates Synthroid (levothyroxine sodium)
No Ubrelvy boxed warning Ubrelvy has Other Warnings No Ubrelvy Indications/Dosage Updates Ubrelvy has Other Updates Ubrelvy (ubrogepant)
No Verquvo boxed warning No Verquvo Other Warnings No Verquvo Indications/Dosage Updates Verquvo has Other Updates Verquvo (vericiguat)
No Vraylar boxed warning Vraylar has Other Warnings Vraylar has Indications/Dosage Updates Vraylar has Other Updates Vraylar (cariprazine)
No Vuity boxed warning Vuity has Other Warnings Vuity has Indications/Dosage Updates Vuity has Other Updates Vuity (pilocarpine hydrochloride)

Get more information on PDR's monthly Drug Updates, including the latest in FDA news.

View the latest drug updates

To have full prescribing information faxed or mailed to you, call 1-800-261-2313.

The FDA encourages healthcare professionals to recognize and report misleading prescription drug advertising. To report: call 855-RX-BADAD (855-792-2323) or email BadAd@fda.gov. For more information, visit www.fda.gov.
Report adverse events to MedWatch.